Issue 12/2009
Content (18 Articles)
Impact of aging on cancer immunity and immunotherapy
Graham Pawelec, Joseph Lustgarten, Carl Ruby, Claudia Gravekamp
Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53
Stefano Salvioli, Miriam Capri, Laura Bucci, Cristina Lanni, Marco Racchi, Daniela Uberti, Maurizio Memo, Daniela Mari, Stefano Govoni, Claudio Franceschi
Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach
Calogero Caruso, Carmela Rita Balistreri, Giuseppina Candore, Giuseppe Carruba, Giuseppina Colonna-Romano, Danilo Di Bona, Giusi Irma Forte, Domenico Lio, Florinda Listì, Letizia Scola, Sonya Vasto
Mechanisms of murine dendritic cell antitumor dysfunction in aging
Annabelle Grolleau-Julius, Lisa Abernathy, Erin Harning, Raymond L. Yung
The effect of aging on OX40 agonist-mediated cancer immunotherapy
Carl E. Ruby, Andrew D. Weinberg
Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged
Yu Cheng Tang, Marilyn Thoman, Phyllis-Jean Linton, Albert Deisseroth
The importance of the age factor in cancer vaccination at older age
Claudia Gravekamp
Cancer, aging and immunotherapy: lessons learned from animal models
Joseph Lustgarten
2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells
Bianca Altvater, Silke Landmeier, Sibylle Pscherer, Jaane Temme, Heribert Juergens, Martin Pule, Claudia Rossig
Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia
Nelson R. Tirone, Bethanea C. Peghini, Ana Cristina M. Barcelos, Eddie F. C. Murta, Marcia A. Michelin
Rejection of intradermally injected syngeneic tumor cells from mice by specific elimination of tumor-associated macrophages with liposome-encapsulated dichloromethylene diphosphonate, followed by induction of CD11b+/CCR3−/Gr-1− cells cytotoxic against the tumor cells
Takeshi Takahashi, Minenori Ibata, Zhiqian Yu, Yosuke Shikama, Yasuo Endo, Yasunori Miyauchi, Masanori Nakamura, Junko Tashiro-Yamaji, Sayako Miura-Takeda, Tetsunosuke Shimizu, Masashi Okada, Koichi Ueda, Takahiro Kubota, Ryotaro Yoshida
A genetic variant of immunoglobulin γ2 is strongly associated with immunity to mucin 1 in patients with breast cancer
Janardan P. Pandey, Paul J. Nietert, Kersti Klaamas, Oleg Kurtenkov
Bortezomib pre-treatment prolongs interferon-alpha-induced STAT1 phosphorylation in melanoma cells
Gregory B. Lesinski, Kristen Benninger, Melanie Kreiner, Megan Quimper, Gregory Young, William E. Carson III
Identification and modification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from Ran antigen
Fan Li, Di Yang, Yiqin Wang, Baohua Liu, Yijing Deng, Li Wang, Xiaoyun Shang, Weidong Tong, Bing Ni, Yuzhang Wu
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts
Robert T. O’Donnell, Yunpeng Ma, Hayes C. McKnight, David Pearson, Joseph M. Tuscano
Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice
Roberto Carrio, Norman H. Altman, Diana M. Lopez
Graft versus neuroblastoma reaction is efficiently elicited by allogeneic bone marrow transplantation through cytolytic activity in the absence of GVHD
Shifra Ash, Vered Gigi, Nadir Askenasy, Ina Fabian, Jerry Stein, Isaac Yaniv